Clinical Study of CVL006 Injection in Advanced Solid Tumors
Phase 1
Not yet recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- Biological: CVL006 Injection
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Convalife (Shanghai) Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT06621615
Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Convalife (Shanghai) Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06519110
Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases
Phase 2
Not yet recruiting
- Conditions
- Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis
- Interventions
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Convalife (Shanghai) Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT06374888
CVL237 Tablets for APDS/PASLI
Phase 2
Not yet recruiting
- Conditions
- PI3K and P110delta Hyperactivation Syndrome
- Interventions
- Drug: CVL237 placebo tabletsDrug: CVL237 tablets
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Convalife (Shanghai) Co., Ltd.
- Target Recruit Count
- 35
- Registration Number
- NCT06293716
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
Phase 2
Not yet recruiting
- Conditions
- Advanced Solid Tumors
- Interventions
- Drug: CVL237 tablets
- First Posted Date
- 2023-12-27
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- Convalife (Shanghai) Co., Ltd.
- Target Recruit Count
- 98
- Registration Number
- NCT06183736
- Locations
- 🇨🇳
Li Ning, Beijing, Beijing, China
Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Convalife (Shanghai) Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT06029816
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath